Telix Pharmaceuticals has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall ...

Artera and Tempus are collaborating to expand access to Artera’s AI-based prostate cancer test. Currently connected to more ...

The Elekta Unity MR-LINAC system, used at Allegheny General Hospital, combines MRI imaging with radiation therapy to target ...

Australian radiopharma company Telix Pharmaceuticals (ASX: TLX) has gained approval from the UK Medicines and Healthcare ...

An emergency physician has pinpointed a trio of "worrying" symptoms that might signal a lethal cancer accountable for nearly ...

In the next in our series, GP Dr Roger Henderson debunks common myths about prostate cancer – and highlights some less ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United Kingdom (UK) Medicines and Healthcare Products Regulatory Agency (MHRA) has approved the ...

An emergency physician has pinpointed a trio of "worrying" symptoms that might signal a lethal cancer accountable for nearly ...

Profound management will host a conference call at 4:30 p.m. ET to review the financial results and discuss business developments in the period. Fourth Quarter and Full Year 2024 Results Conference ...

The Parliamentary Portfolio Committee on Health has called for the decentralisation of cancer treatment facilities to district hospitals for better management of the disease. Cancer has become the ...

Cade, Telix Group Chief Medical Officer, said, “Telix will feature in four presentations at this year’s ASCO GU, which showcase the depth and differentiation of our therapeutic urologic pipeline, ...